Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 53,148 shares at $17.87 ($950K) on 2024-04-08, disclosed to the SEC on 2024-04-09.
Open-market sale of $950k ACAD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.87 | 8,858 | $158K | 16.7% |
| 2 | $17.87 | 8,858 | $158K | 16.7% |
| 3 | $17.87 | 17,716 | $317K | 33.3% |
| 4 | $17.87 | 17,716 | $317K | 33.3% |
| Total | $17.87 avg | 53,148 | $950K | 100% |
| Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |
| ACAD | SELL | 2024-01-09 | $224K | — | Filing → |